The FDA has granted approval to adjuvant cemiplimab treatment for patients with high-risk cutaneous squamous cell carcinoma ...

A network to connect patients with unused medications with patients in need brought $18 million of free cancer medication while reducing drug waste. YesRx CDR Network, a nonprofit network of cancer ...

Panelists discuss how the subcutaneous nivolumab data demonstrate reassuring safety with minimal grade 3/4 events, how pharmacokinetic equivalency across varied patient weights supports flat dosing, ...

In the phase 3 SURPASS-ET trial, ropeginterferon alfa-2b outperformed anagrelide as second-line therapy for high-risk essential thrombocythemia. Ropeginterferon alfa-2b-njft (Besremi) demonstrated ...

Subcutaneous daratumumab is well tolerated, but ongoing immune monitoring is key to managing infection risk in patients with ...

The use of ctDNA after surgery can provide guidance to patients who may be receiving input on treatment decisions from every ...

An LED-based intraoral device for photobiomodulation therapy was safe and reduced severe oral mucositis in patients with head ...

C, OCN, discusses planning beyond first-line CDK4/6 inhibitors and supportive care strategies for patients with HR+/HER2– ...

Supportive oncology interventions provide a comprehensive approach to oncology, addressing patients’ needs holistically, which start with understanding a patient’s baseline ne ...

Leaders in oncology nursing and advanced practice spotlight the essential role of advanced practice providers in oncology.